RemedyRepack Inc. has recalled Carbamazepine 200 mg tablets, a prescription medication used to treat seizures and nerve pain, because the tablets did not dissolve properly during routine quality testing. Approximately 498 tablets are affected by this recall. When a drug fails dissolution testing, it means the medication may not be absorbed correctly by the body, which could prevent the patient from receiving the necessary dose.
The drug failed to meet 'out-of-specification' dissolution results, meaning the tablets do not break down at the required rate. This could lead to lower-than-intended levels of the medication in a patient's bloodstream, potentially failing to control seizures or manage pain effectively.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.